TRACON Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$3,588,000 and profit margin reached -30%. Total operating expenses were $18,929,000.

Profit Margin

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON): Profit margin
2014 3.59M -6.80M -189.24%
2015 7.90M -24.41M -308.83%
2016 3.44M -27.00M -783.07%
2017 8.75M -19.10M -218.2%
2018 3M -34.95M -1165.3%
2019 0 -22.65M
2020 0 -17.32M
2021 346K -28.72M -8302.31%
2022 0 -29.31M
2023 12.04M -3.58M -29.79%

TCON Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
12.04M0346K003M8.75M3.44M7.90M3.59M
Cost of revenue
14K16K14K12K22K019.35M020.43M4.85M
Gross profit
12.03M-16K332K-12K-22K3M-10.6M3.44M-12.52M-1.25M
Operating exp.
Research and development
12.27M13.88M11.14M8.19M14.53M30.46M19.35M21.56M25.68M7.65M
Selling and marketing
0000000000
Total operating expenses
18.92M27.89M28.69M16.22M22.29M37.74M26.96M29.42M31.37M9.77M
Operating income
-6.89M-27.89M-28.34M-16.22M-22.29M-34.74M-18.21M-25.97M-23.46M-6.17M
Other income (expenses), net
3.31M-1.24M-320K-552K-378K-219K-893K-1.03M-943K-630K
Income before tax
-3.58M-29.13M-28.66M-16.77M-22.67M-34.95M-19.10M-27.00M-24.41M-6.80M
Income tax expense
0177K59K551K-16K12K845K938K892K615K
Net income
-3.58M-29.31M-28.72M-17.32M-22.65M-34.95M-19.10M-27.00M-24.41M-6.80M
Earnings per share
Basic EPS
-2.2-1.4-1.67-38.63-7.47-12.97-227.33-2.13-439.2-113.7
Diluted EPS
-2.19-1.4-1.67-38.57-7.47-12.97-227.33-2.13-439.2-113.7
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source